The main goal of drug delivery systems is to target therapeutic cargoes to desired cells and
to ensure their efficient uptake. Recently a number of studies have focused on designing bio …

With the development of nanomedicine, a mass of nanocarriers have been exploited and
utilized for targeted drug delivery, including liposomes, polymers, nanoparticles, viruses …

Evolution of nanomedicine is the re-design of synthetic and biological carriers to implement
novel theranostic platforms. In recent years, bacteriophage research favors this process …

Bacteriophages (Phages) are antibacterial viruses that are unaffected by antibiotic drug
resistance. Many Phase I and Phase II phage therapy clinical trials have shown acceptable …

Background Targeted drug-carrying phage nanomedicines are a new class of
nanomedicines that combines biological and chemical components into a modular …

Bacteriophage-based medical research provides the opportunity to develop targeted
nanomedicines with heightened efficiency and safety profiles. Filamentous phages also can …

Background Systemic administration of chemotherapeutic agents, in addition to its anti-
tumor benefits, results in indiscriminate drug distribution and severe toxicity. This …

With the emergence and spread of global antibiotic resistance and the need for searching
safer alternatives, there has been resurgence in exploring the use of bacteriophages in the …

Bacterial resistance against antibiotics is an emergent medical issue. The development of
novel therapeutic approaches is urgently needed and, in this context, bacteriophages …

Delivery of therapeutic compounds to the site of action is crucial. While many chemical
substances such as beta-lactam antibiotics can reach therapeutic levels in most parts …